Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    American Society of Clinical Oncology (ASCO) ; 2018
    In:  Journal of Clinical Oncology Vol. 36, No. 15_suppl ( 2018-05-20), p. e24284-e24284
    In: Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 36, No. 15_suppl ( 2018-05-20), p. e24284-e24284
    Type of Medium: Online Resource
    ISSN: 0732-183X , 1527-7755
    RVK:
    RVK:
    Language: English
    Publisher: American Society of Clinical Oncology (ASCO)
    Publication Date: 2018
    detail.hit.zdb_id: 2005181-5
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2015
    In:  BMC Cell Biology Vol. 16, No. 1 ( 2015-12)
    In: BMC Cell Biology, Springer Science and Business Media LLC, Vol. 16, No. 1 ( 2015-12)
    Type of Medium: Online Resource
    ISSN: 1471-2121
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2015
    detail.hit.zdb_id: 2964981-X
    detail.hit.zdb_id: 2041486-9
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2021
    In:  Cancer Research Vol. 81, No. 4_Supplement ( 2021-02-15), p. PS18-30-PS18-30
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 81, No. 4_Supplement ( 2021-02-15), p. PS18-30-PS18-30
    Abstract: Background: The Ras signaling pathway is a key oncogenic growth signaling pathway. The neurofibromatosis gene (NF1) is a tumor suppressor gene and negative regulator of Ras. Approximately 20% of breast cancers experience loss of active NF1 protein, leading to unabated Ras activity. Germline inactivation of NF1 leads to neurofibromatosis, which can be treated with MEK inhibitors. The functional consequences of NF1 loss have not been thoroughly explored in breast cancer. Therefore, we created a cellular model for the loss of NF1 in breast cells in order to identify novel therapies that would target NF1 null breast cells. Methods: We used CRISPR CAS9 to knock out (KO) NF1 through targeted disruption of both NF1 alleles in the human non-tumorigenic breast cell line MCF-10A. Immunoblotting confirmed loss of the protein and this cell line was used to identify changes in cellular signaling that resulted from the loss of NF1. We then used a rational approach to select drugs that may target the cellular changes in NF1 null cells. Finally, the candidate drugs were tested in a tumor xenograft model in mice. Results: Loss of NF1 endowed cells with a more transformed phenotype, including EGF growth independence and anchorage-independent growth. We observed increased activation of MAPK and activated Rho GTPase. The MEK inhibitors trametinib and PD0325901 (IC50=0.25 nM and 0.16 nM, respectively) inhibited growth of NF1-null, but not parent cells. We explored inhibitors of other proteins in the MAPK signaling pathway, including the Raf inhibitors sorafenib and vemurafenib and the dual MAP3K1/MAP2K4 inhibitor LY2228820. However, these compounds did not selectively inhibit growth of NF1-null cells, suggesting that Raf and MAP3K1/MAP2K4 are not vulnerable targets in NF1-null cells. Vincristine and zoledronic acid can indirectly affect Rho GTPase function. NF1-null cells were more sensitive to both as single agents (IC50=1.1 nM and 6.9 μM, respectively) than parental cells. We also tested multiple combinations of these drugs and observed benefits from several combinations that exceeded single agent use. Similar sensitivity was not observed to docetaxel or ixabepilone. We then tested the drugs as single agents and in combination against mouse tumor xenograft models with the human breast cancer cell lines Hs578T (NF1 null) or MCF-7 (wild type NF1). Treatment with single agent vincristine or zoledronic acid for 19 days resulted in statistically-significant decreases of 37.3% and 38.9%, respectively (p & lt;0.05) in Hs578T tumor xenografts. The combination treatment resulted in an enhanced reduction in tumor size of 48.8% with a higher level of significance (p & lt;0.01). Treatment of mice with MCF-7 bearing tumors with single agent vincristine resulted in a statistically significant decrease of 35.2% (p & lt;0.05); however, this effect was not observed using the combination treatment, as the change in growth compared to saline treatment was not statistically significant. Conclusions: Our results suggest that loss of NF1 results in a transformed phenotype. Our results provide the first evidence that vincristine in combination with zoledronic acid may be efficacious in treating breast cancers. Additionally, we provide evidence that other drugs and drug combinations may be more effective at treating breast cancers with NF1 loss than MEK inhibitors, warranting further exploration. Citation Format: Melody A. Cobleigh, Matthew Najor, Satnam Brar, Sanja Turturro, Liam Portt, Timothy Yung, Abde M Abukhdeir. Loss of NF1 leads to rho GTPase activation and sensitivity to multiple agents in breast cancer [abstract]. In: Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2021;81(4 Suppl):Abstract nr PS18-30.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2021
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    In: International Journal of Cancer, Wiley, Vol. 143, No. 8 ( 2018-10-15), p. 1994-2007
    Abstract: What's new? Pancreatic ductal adenocarcinoma is characterized by mutations in the proto‐oncogene KRAS and proinflammatory macrophage infiltration, but a mechanistic link between both conditions remains unknown. Here the authors used murine pancreatic organoid models to demonstrate cooperativity between epithelial cells carrying mutant KRAS and invading macrophages in pancreatic neoplastic transformation. These results encourage more research into the bidirectional epithelium–macrophage cross‐talk as it could reveal novel targets for pancreatic cancer therapy.
    Type of Medium: Online Resource
    ISSN: 0020-7136 , 1097-0215
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2018
    detail.hit.zdb_id: 218257-9
    detail.hit.zdb_id: 1474822-8
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    In: Biomaterials, Elsevier BV, Vol. 32, No. 14 ( 2011-05), p. 3620-3626
    Type of Medium: Online Resource
    ISSN: 0142-9612
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2011
    detail.hit.zdb_id: 2004010-6
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2014
    In:  SpringerPlus Vol. 3, No. 1 ( 2014-12)
    In: SpringerPlus, Springer Science and Business Media LLC, Vol. 3, No. 1 ( 2014-12)
    Abstract: Optineurin is a gene associated with normal tension glaucoma (NTG) and amyotrophic lateral sclerosis (ALS). Foci formation and functional consequences including Golgi fragmentation, impairment of vesicle trafficking and apoptosis were observed previously upon overexpression and/or mutation of optineurin. In the current study, a total of 15 GFP tagged constructs that included NTG (E50K and 2 bp-AG insertion), ALS (exon 5 deletion, R96L, Q398X, and E478G) and non-disease (L157A and D474N) associated mutants and a series of deletion fragments were cloned into mammalian expression vectors and transfected into RGC5 and/or Neuro2A cells to evaluate whether their expression confer the optineurin phenotypes. The cells were monitored for foci formation and stained by immunofluorescence with anti-GM130 to analyze the Golgi integrity. Transferrin uptake experiments were performed to evaluate the protein trafficking process and apoptosis was assessed with the active caspase 3/7 detection kit. We demonstrated that cells expressing E50K and R96L optineurin exhibited all of the optineurin phenotypes. Q398X mutant did not induce foci formation, but triggered Golgi fragmentation, impairment of transferrin uptake and increase in apoptosis. The 2 bp-AG insertion mutant had a nuclear localization, compromised the transferrin uptake and strongly induced apoptosis. The foci formation, which might not predict the rest of the phenotypes, appeared to require both the leucine zipper and ubiquitin binding domains of the optineurin sequence. Interactions of optineurin with proteins including Rab8, myosin VI, huntingtin and transferrin receptor might directly determine whether the Golgi and protein trafficking phenotypes would be manifested. Examination of mutants and deletion fragments located at various sites of optineurin gene provide clues as to what regions of the gene may play a critical role in the development of pathologic consequences.
    Type of Medium: Online Resource
    ISSN: 2193-1801
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2014
    detail.hit.zdb_id: 2661116-8
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2016
    In:  Breast Cancer Research and Treatment Vol. 156, No. 1 ( 2016-2), p. 33-43
    In: Breast Cancer Research and Treatment, Springer Science and Business Media LLC, Vol. 156, No. 1 ( 2016-2), p. 33-43
    Type of Medium: Online Resource
    ISSN: 0167-6806 , 1573-7217
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2016
    detail.hit.zdb_id: 2004077-5
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2019
    In:  Breast Cancer Research and Treatment Vol. 177, No. 2 ( 2019-9), p. 325-333
    In: Breast Cancer Research and Treatment, Springer Science and Business Media LLC, Vol. 177, No. 2 ( 2019-9), p. 325-333
    Type of Medium: Online Resource
    ISSN: 0167-6806 , 1573-7217
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2019
    detail.hit.zdb_id: 2004077-5
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    In: Proceedings of the National Academy of Sciences, Proceedings of the National Academy of Sciences, Vol. 110, No. 6 ( 2013-02-05)
    Abstract: In addition to retinal defects, miR-183/96/182 –mutant mice exhibited a circling behavior typical of defects in vestibular organs, suggesting the presence of syndromic sensory defects and that the requirement for the miR-183/96/182 gene for normal functions of sensory organs other than the retina. Studies on genetic variations around miR-183/96/182 gene are warranted in patients with progressive, sensory syndromic retinal dysfunction and other neurological conditions. In mouse, both rod and cone photoreceptor differentiation and synaptogenesis occur postnatally starting from postnatal day 4–5 ( 4 ), coincident with developmental up-regulation of the miR-183/96/182 gene ( 1 ). Our data suggest that miR-183/96/182 is required for postnatal differentiation of photoreceptors and establishment of fully functional synaptic connections with their downstream neurons by directly and indirectly regulating genes important for synaptic functions and the phototransduction pathway. Inactivation of the miR-183/96/182 gene disrupts the homeostasis and functions of photoreceptors, leading to progressive retinal dysfunction and degeneration ( Fig. P1 E ). Many genes known to be involved in phototransduction, a process by which light signals are transformed into neuroelectrical impulses in photoreceptors, also were dysregulated. We confirmed that the expression of red/green opsin was decreased significantly. Quantification of red/green opsin-positive and total cones in the whole-mount retina showed that both the number and the percentage of red/green opsin-positive cones were decreased significantly in the superior retina, but in the inferior retina the total number of cones and the number of red/green opsin-positive cones did not change significantly, suggesting that red/green cones were the most affected photoreceptors and that the greater vulnerability of red/green cones contributed to more severe defects in photopic ERGs and more degeneration in the superior retina in miR-183 / 96/182 –mutant mice. Gene-expression profiling revealed global gene-expression changes in retinas of 5-wk-old miR-183/96/182 –mutant mice. Genes important for synaptogenesis, nerve-impulse transmission, and synaptic remodeling were enriched significantly in the dysregulated genes, consistent with ERG data indicating abnormal synaptic transmission of photoreceptors. Electron microscopy and immunostaining with synaptic markers confirmed that the sizes of synaptic ribbons were decreased significantly in the mutant mice as early as age 5 wk. A light-damage experiment showed significantly increased degeneration in the retinas of the mutant mice as compared with wild-type littermates after a 2-h exposure to 10,000-lx cool, white fluorescent light. In this experiment, as with aging, the superior retina was more damaged than the inferior retina, consistent with a recent report in a miR-183/96/182 knockdown mouse model ( 2 ). Histologically, despite significant ERG abnormalities, retinas of 5-wk-old mutant mice were indistinguishable from littermate controls. By 6 mo, however, the mutant mice showed significant retinal degeneration, which progressed at 1 y of age ( Fig. P1 D ) . Intriguingly, the superior retina, which is enriched with red/green cones, was more affected than the inferior retina, which is enriched with blue cones. To study the functions of miR-183/96/182 , we generated a mouse model in which the miR-183/96/182 gene is inactivated. Functionally, inactivation of the miR-183/96/182 gene resulted in early-onset, progressive electroretinogram (ERG) abnormalities. The most prominent defect, decreased b -wave amplitude, was common to both dark-adapted and light-adapted ERGs in the mutant mice ( Fig. P1 B and C ) and was detectable as early as 5 wk of age. The ERG b wave is derived mostly from activities of secondary neuron-bipolar cells; defects in bipolar cells and photoreceptor synaptic transmission can produce defective b waves ( 3 ). Because miR-183/96/182 is expressed predominantly in photoreceptors, reduction in b -wave amplitude likely reflects synaptic transmission defects in photoreceptors of miR-183/96/182 –mutant mice. The amplitude, latency, and implicit time of the a wave, which reflects the activities of photoreceptors, appeared normal in 5-wk-old mutant mice but became defective with age. In all parameters, light-adapted ERG was more affected than dark-adapted ERG, suggesting more severe defects in the cone pathways. We first dissected the genomic structure of the gene encoding miR-183/96/182 and showed that the miR-183/96/182 gene produces at least two primary RNA molecules, the transcripts ( Fig. P1 A ). The structure of the second transcript clearly positions miR-183/96/182 in the intron of the gene. The second transcript has four predicted protein-coding regions, suggesting that the miR-183/96/182 gene may encode one or more peptides. Previously, we identified a cluster of miRNAs—small, noncoding, regulatory RNAs—that appears to be evolutionarily conserved and specifically expressed in sensory organs ( 1 ). Expression of this miR-183/96/182 cluster (also referred to as “ miR-183/96/182 ”) is minimal in embryonic retina but increases dramatically after birth and peaks in adult retina with specific expression in photoreceptors ( 1 ). Reducing the expression of miR-183/96/182 in rod photoreceptors increased light damage to the mouse retina ( 2 ), but no histological or functional defects of the retina were observed under normal lighting conditions ( 2 ). Thus, in vivo functions of miR-183/96/182 in the retina remain uncertain.
    Type of Medium: Online Resource
    ISSN: 0027-8424 , 1091-6490
    RVK:
    RVK:
    Language: English
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date: 2013
    detail.hit.zdb_id: 209104-5
    detail.hit.zdb_id: 1461794-8
    SSG: 11
    SSG: 12
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    American Chemical Society (ACS) ; 2013
    In:  Molecular Pharmaceutics Vol. 10, No. 8 ( 2013-08-05), p. 3023-3032
    In: Molecular Pharmaceutics, American Chemical Society (ACS), Vol. 10, No. 8 ( 2013-08-05), p. 3023-3032
    Type of Medium: Online Resource
    ISSN: 1543-8384 , 1543-8392
    Language: English
    Publisher: American Chemical Society (ACS)
    Publication Date: 2013
    detail.hit.zdb_id: 2132489-X
    SSG: 15,3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages